228 related articles for article (PubMed ID: 32670354)
21. Integrative molecular analysis of metastatic hepatocellular carcinoma.
Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
[TBL] [Abstract][Full Text] [Related]
22. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
[TBL] [Abstract][Full Text] [Related]
23. Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.
Zhang J; Zhang X; Wang L; Kang C; Li N; Xiao Z; Dai L
PeerJ; 2021; 9():e12197. PubMed ID: 34616632
[TBL] [Abstract][Full Text] [Related]
24. Metabolic Pathways Enhancement Confers Poor Prognosis in p53 Exon Mutant Hepatocellular Carcinoma.
Chen PM; Li JR; Liu CC; Tang FY; Chiang EI
Cancer Inform; 2020; 19():1176935119899913. PubMed ID: 31933519
[TBL] [Abstract][Full Text] [Related]
25. Mining featured biomarkers associated with vascular invasion in HCC by bioinformatics analysis with TCGA RNA sequencing data.
Zhang R; Ye J; Huang H; Du X
Biomed Pharmacother; 2019 Oct; 118():109274. PubMed ID: 31545220
[TBL] [Abstract][Full Text] [Related]
26. Multi-omics analysis reveals critical metabolic regulators in bladder cancer.
Wei C; Deng C; Dong R; Hou Y; Wang M; Wang L; Hou T; Chen Z
Int Urol Nephrol; 2024 Mar; 56(3):923-934. PubMed ID: 37882969
[TBL] [Abstract][Full Text] [Related]
27. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
[TBL] [Abstract][Full Text] [Related]
28. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
29. An integrated analysis of genome-wide DNA methylation and gene expression data in hepatocellular carcinoma.
Sun XJ; Wang MC; Zhang FH; Kong X
FEBS Open Bio; 2018 Jul; 8(7):1093-1103. PubMed ID: 29988590
[TBL] [Abstract][Full Text] [Related]
30. Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.
Li J; Chen N; Gong X
Mol Med Rep; 2019 Dec; 20(6):5304-5314. PubMed ID: 31661127
[TBL] [Abstract][Full Text] [Related]
31. Multiomics Integration at Single-Cell Resolution Using Bayesian Networks: A Case Study in Hepatocellular Carcinoma.
Jihad M; Yet İ
OMICS; 2023 Jan; 27(1):24-33. PubMed ID: 36602810
[TBL] [Abstract][Full Text] [Related]
32. Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.
Liao H; Liao M; Xu L; Yan X; Ren B; Zhu Z; Yuan K; Zeng Y
EBioMedicine; 2019 Mar; 41():310-319. PubMed ID: 30665854
[TBL] [Abstract][Full Text] [Related]
33. Integrative analysis of layers of data in hepatocellular carcinoma reveals pathway dependencies.
Bhat M; Pasini E; Pastrello C; Rahmati S; Angeli M; Kotlyar M; Ghanekar A; Jurisica I
World J Hepatol; 2021 Jan; 13(1):94-108. PubMed ID: 33584989
[TBL] [Abstract][Full Text] [Related]
34. Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
Zhang J; Chen G; Zhang J; Zhang P; Ye Y
Am J Transl Res; 2020; 12(9):5108-5130. PubMed ID: 33042409
[TBL] [Abstract][Full Text] [Related]
35. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
[TBL] [Abstract][Full Text] [Related]
36. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
37. Genetic Alterations and Transcriptional Expression of m
Zhu GQ; Yu L; Zhou YJ; Du JX; Dong SS; Wu YM; Shi YH; Zhou J; Fan J; Dai Z
Front Oncol; 2020; 10():900. PubMed ID: 32850303
[No Abstract] [Full Text] [Related]
38. Weighted Gene Coexpression Network Analysis Reveals the Dynamic Transcriptome Regulation and Prognostic Biomarkers of Hepatocellular Carcinoma.
Qu S; Shi Q; Xu J; Yi W; Fan H
Evol Bioinform Online; 2020; 16():1176934320920562. PubMed ID: 32523331
[TBL] [Abstract][Full Text] [Related]
39. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
40. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
Yang MR; Zhang Y; Wu XX; Chen W
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
